Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The evolving pattern of calciphylaxis: therapeutic considerations

F Llach

    Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
    |March 10, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prostaglandin E1 increases in vivo and in vitro calcitriol biosynthesis in rabbits.

    Prostaglandins, leukotrienes, and essential fatty acids·2006
    Same author

    Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
    Same author

    Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
    Same author

    Paricalcitol dosing according to body weight or severity of hyperparathyroidism: a double-blind, multicenter, randomized study.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
    Same author

    Current medical management of secondary hyperparathyroidism.

    The American journal of the medical sciences·2000
    Same author

    Hyperphosphatemia in end-stage renal disease patients: pathophysiological consequences.

    Kidney international. Supplement·2000